Analysing the Socio-economic Factors Causing Hepatitis B and C in Balochistan A Case Study of Quetta District
Keywords:
Hepatitis (HBV) and (HCV), causes, impacts, Quetta, BalochistanAbstract
Hepatitis (HBV) and (HCV) are viruses of liver infections. It transpire
without symptoms but can prime to jaundice a yellow discoloration of
the skin, mucous membranes and conjunctiva of the eyes, poor appetite
and tiredness and it might reason acute or as a chronic infection. This
study analyzed the socioeconomic factors which seemingly caused
hepatitis B, C in Quetta Balochistan. Out of 300 patients registered in
Bolan Medical College and Civil hospital were interviewed and
primary data were collected by questionnaire and statistical tools.
Findings showed that main causes which were caused of hepatitis
(HBV) and (HCV) of people they used personal razors of infected
patients, common nail caliper of other people, root canal treatment
(RCT) got blood unsafe blood transfusion, unsafe surgery, used tooth
brush of other people at home, ate fruits without washing, used unsafe
injection, injected drugs were the main caused hepatitis.
References
Abbasi,S., Faqir, F., Khan, S., Zaidi,S.K., Ahmed, S.Q, Sattar, A., and
Satti, M.(2011). A serological study of hepatitis C and human
Immunodeficiency virus in a cohort, of intravenous drug users in
Quetta, Balochistan, journal of postgraduate medical
institute(Peshawar- Pakistan),23(1).
Aband ,B.S (2009),Management of hepatitis (C) virus infection in
(HBV), (HCV) ,Co-infected patients clinical review J- Gastroenterol.
Ali, S. A., Donahue, R. M., Qureshi, H., & Vermund, S. H. (2009).
Hepatitis B and hepatitis C in Pakistan: prevalence and risk
factors. International journal of infectious diseases, 13(1), 9-19.
Adaauria ( 2011) prevalence of hepatitis B virus and C virus makers in
surgeons in logos, south Asia,Afr,Med
Afzal, M. S., Shah, Z. H., & Ahmed, H. (2016). Recent HCV genotype
changing pattern in the Khyber Pakhtunkhwa province of Pakistan; is
it pointing out a forthcoming problem? Brazilian Journal of Infectious
Diseases, 20(3), 312-313.
Ahmed N, Asgher M.Shafique, M Qureshi, J.A, 2007, an evidence of
high prevalence of hepatitis C virus in Faisalabad Pakistan.
Asif,khan, Ali.M, Ahmed J, prevalence of hepatitis B, C antigenaema
in general population of Asia, .(2010).
. Bosan, A., Qureshi, H., Bile, K. M, Ahmed, I, Hafiz, R. (2010).
A,Review of hepatitis viral infections in Pakistan. J Pak, Med
.Assoc, 60(12),1045-58.
Daw, M. A., & El-Bouzedi, A. (2014). Prevalence of hepatitis B and
hepatitis C infection in Libya: result from a national population based
survey. BMC infectious diseases, 14(1), 17
Hanafiah, K, Mohd, Groeger, J., Flaxman, A. D., & Wiersma, S. T.
(2013). Global epidemiology of hepatitis C virus infection: New
estimates of age‐specific antibody to HCV
seroprevalence. Hepatology, 57(4), 1333-1342.
Health care control programe of hepatitis,B,C., Government of
Pakistan, (2007).
HYPERLINK "https://en.wikipedia.org/wiki/Hepatitis"
https://en.wikipedia.org/wiki/Hepatitis (hbv) and (hcv) viral
infections, (2017).
Jamieson, 2015), J., Bocchini Jr, J. A., Hariri, S., Chesson, H., Curtis,
C. R., Saraiya, M., ... & Centers for Disease Control and Prevention
(CDC). (2015). Use of (BC) vaccine: updated, vaccination
recommendations of the advisory committee on immunization
practices.
Khan, A, Tareen, A.M, Ikram, A., Rahman, H., Wadood, A, Qasim, M,
and Khan, K (2013). Prevalence of (HCV) among the young male
blood donors of Quetta region of Balochistan, Pakistan virology,
Journal , 10(1), 1.
Khan ,Wi, Sultana R. Rahman M, Akhtar H, Haq, JA. Ali, L. Mohsin.
MA, Khan, AK: Viral hepatitis ,recent experiences from serological
studies in Bangladash, Asian Pac. J. Alleergy, Immunol( 2011).
Kourtis, A. P., Bulterys, M., Hu, D. J., & Jamieson, D. J. (2012).
HCV–HBV coinfection—A global challenge. New England Journal of
Medicine, 366(19), 1749-1752
Lavanchy, D. (2009). The global burden of hepatitis C. Liver
International , 29(S1), 74-81.
Locarnini, S., Hatzakis, A., Chen, D. S., & Lok, A. (2015). Strategies
to control hepatitis B: Public policy, epidemiology, vaccine and
drugs. Journal of hepatology, 62(1), S76-S86
Mahmood, M. A., Khawar, S., Anjum, A. H., Ahmed, S. M., Rafiq, S.,
Nazir, I., & Usman, M. (2016). Prevalence of hepatitis B, C and
infection in blood donors of Multan region. Annals of King Edward
Medical University, 10(4).
Mohd Hanafiah, K., Groeger, J., Flaxman, A. D., & Wiersma, S. T.
(2013). Global epidemiology of hepatitis C virus infection: New
estimates of age‐specific antibody to HCV
seroprevalence. Hepatology, 57(4), 1333-1342
Messina, J. P., Humphreys, I., Flaxman, A., Brown, A., Cooke, G. S.,
Pybus, O. G., & Barnes, E. (2015). Global distribution and prevalence
of hepatitis C virus genotypes. Hepatology, 61(1), 77-87.
National Survey of Pakistan (2007) National survey on prevalence of
hepatitis B and C in general population of Pakistan (2007).
Ola.so, Odaibo.GN. - feto ,protein (HCV) and (HBV) infection in
Negirian patients with primary hepatocellular Carcinoma, Niger,
Med,(2007).51.35.5.
Umar, M., & Bilal, M. (2012). Hepatitis C, a mega menace: a Pakistani
Perspective. Journal of Pioneering Medical Sciences, 2(2), 68.
UNICEF, B.C, Vaccination (2009): “Burden of pediatric hepatitis B,
C, World J Gastroenterol (2009) November 28, 19 (44): 7880-7888
Uolk et al, Van Handel, M., Wolitski, R. J., Stryker, J. E., Hall, H. I.,
Prejean, J., & Valleroy, L. A. (2009). Vital signs: estimated
percentages with indications Hepatitis BC for preexposure prophylaxis
to prevent BC—United States.
World Health Organization (2004) Global burden of disease. GDB, for
hepatitis C, C.J- clin-pharmacol(2004).
World Health Organization (2013). Global policy report on the
prevention and control of viral hepatitis in WHO Member States.
(World Health Organization).
World health organization/ WHA, World health Assembly (2010)
18 in recognition of viral hepatitis as a global public health Problem
(7)
World Health Assembly Resolution (2010) 63.18.Viral Hepatitis. In:
sixty-third world Health
Assembly,Agena,item11.12,21may.2010.Geneva:WHO,2010(
HYPERLINK "http://apps.who.int/gb/ebwha/pdf-files/wha63-REC/WHA63-
REC-en.pdf-" http://apps.who.int/gb/ebwha/pdf-files/wha63-
REC/WHA63-REC-en.pdf- ,accessed29 February 2016).
HBV, HCV, International Innovation (2014): : Hepatitis BC
,Worldwide and in silent epidemic- data on disease including
Incidence, transmission, prevention, and treatment”, Scientific World,
”2014: 827849.doi:10.1155/2014/Epub.Jun 10
Zaidi, AK, Awasthi S, Desilva, HJ, Burden of infectious in South Asia,
BMT. ( 2004).328:811-5
